Browsing Tag
Baird
5 posts
Mirum Pharmaceuticals (NASDAQ: MIRM) jumps 13% after VISTAS Phase 2b PSC win
Two Phase 2b wins in seven days. A pre-NDA meeting this summer. Mirum is starting to look less like a single-product rare disease story.
Immutep (ASX: IMM) surges 48% on FDA orphan drug designation: Is the STS pivot the new thesis?
Immutep (ASX: IMM) jumped 48% after the FDA granted orphan drug status for eftilagimod alfa in soft tissue sarcoma. Here is what the EFTISARC-NEO data means for the investment case.
Artemis acquires Millrock Technology to expand lyophilization innovation in life sciences
Artemis Capital Partners acquires Millrock Technology to scale lyophilization systems, fueling growth in biologics, vaccines, and diagnostics innovation.
BPM provider WNS shares plunge 12% following dismal FY25 outlook
Shares of WNS (Holdings) Limited took a substantial hit, plunging 12%, after the company delivered a downbeat fiscal…
GSE Solutions to be acquired by Pelican Energy Partners in all-cash deal
In a pivotal move within the clean-energy sector, GSE Solutions, formally known as GSE Systems, Inc. (Nasdaq: GVP),…